Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

Gary Wittert, Karen Bracken, Kristy Robledo, Mathis Grossmann, Bu B. Yeap, David J. Handelsman, Bronwyn Stuckey, Ann J. Conway, Warrick J. Inder, Robert I. McLachlan, Carolyn A Allan, David Jesudason, Mark Ng Tang Fui, Wendy Hague, Alicia J. Jenkins, Mark Daniel, Val Gebski, Anthony Keech